Hims vs Calibrate 2026: GLP-1 Weight Loss Programs Compared
An in-depth comparison of Hims and Calibrate for GLP-1 weight loss in 2026. We examine pricing, program models, medication options, clinical support, and flexibility to help you choose the right provider.
Written by Trimi Medical Team
Medically reviewed by Dr. Amanda Foster, MD
Last updated 2026-04-08
More on GLP-1 Provider Comparisons
Hims vs Calibrate: Two Different Models for GLP-1 Weight Loss
If you are comparing Hims vs Calibrate for GLP-1 weight loss, the first thing to understand is that these two providers operate on fundamentally different models. Hims is a month-to-month, app-based telehealth platform that provides direct access to compounded semaglutide and tirzepatide without long-term contracts. Calibrate is a year-long, coaching-intensive program built around a structured "metabolic reset" framework that combines GLP-1 medication with behavioral interventions across food, exercise, sleep, and emotional health.
Hims vs Calibrate, defined: Hims offers flexible, subscription-style GLP-1 prescriptions through its telehealth app at $149 to $299 per month depending on medication type. Calibrate requires a $1,649 annual program fee plus separate medication costs, bundling intensive coaching and metabolic lab work into a comprehensive twelve-month commitment. Both are legitimate telehealth providers, but their cost structures, flexibility, and support models differ significantly.
The clinical evidence supporting GLP-1 medications for weight loss is robust regardless of which provider you choose. The STEP 1 trial demonstrated that semaglutide 2.4 mg produced 14.9% mean body weight loss over 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SURMOUNT-1 trial showed tirzepatide at the highest dose achieved 22.5% body weight reduction over 72 weeks (Jastreboff et al., NEJM, 2022). The medication works the same way whether dispensed through Hims, Calibrate, or any other licensed provider.
Key Takeaway
Hims and Calibrate represent opposite ends of the telehealth GLP-1 spectrum. Hims prioritizes accessibility and flexibility with month-to-month pricing. Calibrate prioritizes comprehensiveness with a structured year-long program. Both charge significantly more than Trimi, which offers semaglutide at $99/mo and tirzepatide at $125/mo with no contracts.
Hims vs Calibrate vs Trimi: Side-by-Side Comparison
The following table compares all three providers across the factors that matter most when choosing a GLP-1 weight loss program: cost, flexibility, clinical support, and medication access.
| Feature | Hims | Calibrate | Trimi |
|---|---|---|---|
| Semaglutide cost | $149-$199/mo | $1,649/yr + med costs | $99/mo |
| Tirzepatide cost | $199-$299/mo | $1,649/yr + med costs | $125/mo |
| Medication included in price | Yes | Often separate | Yes |
| Contract commitment | None (month-to-month) | 12 months | None (month-to-month) |
| Program fee | None | $1,649/year | None |
| Coaching / behavioral support | App-based tools | 1:1 coaching + curriculum | Clinical guidance |
| Lab work required | No | Yes (metabolic panel) | No (available if needed) |
| Provider consultations | Async messaging | Scheduled visits | Included |
| Cancellation penalties | None | May apply | None |
| Time to start medication | Days | Weeks (labs + onboarding) | Days |
| 12-month total (semaglutide) | $1,788-$2,388 | $3,000-$6,000+ | $1,188 |
| Best for | Flexible, app-based GLP-1 access | Comprehensive coaching + structured program | Best value for clinical GLP-1 care |
Pricing Breakdown: Calibrate's Commitment vs Hims' Monthly Model
The pricing structures of Hims and Calibrate could not be more different. Understanding exactly what you pay and when you pay it is essential before committing to either platform.
Hims Pricing Model
Hims operates on straightforward monthly billing. Compounded semaglutide costs $149 to $199 per month and compounded tirzepatide costs $199 to $299 per month. These prices include the medication, provider consultation, and shipping. There is no upfront fee, no program charge, and no long-term contract. You pay each month and can cancel at any time. Over twelve months on semaglutide, a Hims patient pays approximately $1,788 to $2,388 total. For patients who want to explore Hims side effects before committing, see our detailed Hims weight loss side effects guide.
Calibrate Pricing Model
Calibrate uses a fundamentally different structure. Patients pay a $1,649 annual program fee that covers coaching, curriculum, metabolic lab work, and provider consultations over twelve months. This fee can often be broken into monthly installments of roughly $135 to $150 per month, but the full-year obligation remains regardless of payment frequency. The critical detail is that medication costs are frequently separate from the program fee. If insurance covers your GLP-1, you pay your copay on top of the program fee. If insurance does not cover it, you face brand-name pricing that can exceed $1,000 per month in addition to the program fee. In the worst case, a Calibrate patient without medication coverage could spend $3,000 to $6,000 or more annually. Learn about Calibrate-specific considerations in our Calibrate side effects guide.
Annual Cost Comparison
Twelve months on semaglutide: Hims costs $1,788-$2,388, Calibrate costs $3,000-$6,000+, and Trimi costs $1,188. The difference between Calibrate and Trimi can exceed $4,800 per year. Even Hims costs $600 to $1,200 more annually than Trimi. For the most affordable options, review our cheapest GLP-1 injections guide.
What the Price Difference Buys
The price gap between Hims and Calibrate is not arbitrary. Calibrate's higher cost reflects a fundamentally more comprehensive program. The $1,649 annual fee pays for one-on-one health coaching sessions, a structured twelve-month curriculum covering nutrition science, exercise programming, sleep optimization, and emotional health management, metabolic lab work and biomarker tracking, and regular physician consultations beyond basic prescription management. Whether these services are worth the premium depends on your individual needs.
Hims' lower price reflects a leaner model. You receive the GLP-1 medication, asynchronous provider communication through the app, weight-tracking tools, and educational content. There is no dedicated coach, no structured curriculum, and no lab work. For many patients, the medication itself is the primary driver of weight loss outcomes, and the supplementary services offered by Calibrate represent optional rather than essential support.
Program Model Differences: Flexibility vs Structure
The Hims vs Calibrate comparison fundamentally comes down to how much structure and support you want around your GLP-1 medication. These two platforms represent nearly opposite philosophies about what a weight loss program should look like.
Hims: The Flexibility-First Approach
Hims treats GLP-1 weight loss as a medical service you subscribe to, similar to how you might subscribe to any other health product on their platform. The onboarding process is designed for speed: complete an online health assessment, receive a provider review, and get medication shipped to your door within days. The app provides a dashboard for tracking weight, messaging your provider, and accessing educational content, but there is no structured program or coaching layer on top.
The advantage of this model is maximum flexibility. You start when you want, adjust when you need to, and stop when you choose. There is no sunk cost in a program fee and no financial penalty for pausing treatment. For patients who are self-directed, already knowledgeable about nutrition and exercise, or who prefer to manage their own behavioral changes alongside medication, this lightweight model provides what they need without paying for services they would not use. If you are considering switching away from Hims, see our guide to canceling Hims and switching providers.
Calibrate: The Structure-First Approach
Calibrate's metabolic reset program is built on the premise that sustainable weight loss requires more than medication alone. The twelve-month program walks patients through a sequenced curriculum covering the four pillars of metabolic health: food, exercise, sleep, and emotional well-being. Each patient is assigned a dedicated health coach who helps translate curriculum content into practical daily habits.
The program begins with comprehensive metabolic lab work that establishes baseline biomarkers. This data informs the initial treatment plan and provides measurable checkpoints for progress tracking. Regular coaching sessions provide accountability and personalized guidance. The structured nature means patients follow a defined path rather than figuring out the behavioral components on their own. For patients considering whether to leave Calibrate's program, review our guide to canceling Calibrate.
The disadvantage is that this structure comes at a significant financial and commitment cost. The year-long obligation means that even if you discover within three months that the coaching is not useful to you, you remain financially responsible for the full program. Patients who are already health-literate and self-motivated often report that the coaching and curriculum do not add proportional value to justify the premium over leaner options.
Clinical Evidence: The Medication Works Regardless of Provider
One of the most important facts in the Hims vs Calibrate debate is that the clinical evidence supporting GLP-1 medications applies equally regardless of which platform dispenses them. Semaglutide and tirzepatide produce their weight loss effects through direct pharmacological mechanisms — suppressing appetite via GLP-1 receptor activation, slowing gastric emptying, and modulating central nervous system hunger signaling — none of which depend on the provider's program model.
The landmark STEP 1 trial enrolled 1,961 adults with obesity or overweight and demonstrated that semaglutide 2.4 mg weekly produced a mean body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo (Wilding et al., New England Journal of Medicine, 2021). Participants receiving semaglutide also showed significant improvements in cardiometabolic risk factors including waist circumference, blood pressure, and glycated hemoglobin.
For tirzepatide, the SURMOUNT-1 trial enrolled 2,539 adults and showed even more impressive results. The highest tirzepatide dose (15 mg weekly) produced 22.5% mean body weight loss over 72 weeks, with 63% of participants losing at least 20% of their body weight (Jastreboff et al., New England Journal of Medicine, 2022). These results established tirzepatide as the most effective GLP-1-based therapy currently available for weight management.
A third relevant study examined whether adding intensive behavioral therapy to semaglutide improves outcomes beyond medication alone. Wadden et al. found that adding structured behavioral intervention to semaglutide produced modestly greater weight loss than medication with standard care, but the incremental benefit was smaller than the difference between semaglutide and placebo (JAMA, 2021). This suggests that while behavioral support adds value, the medication itself is the dominant driver of outcomes — an important consideration when deciding whether Calibrate's premium coaching justifies its cost over Hims' leaner approach.
Evidence Summary
Semaglutide: 14.9% body weight loss over 68 weeks (STEP 1, Wilding et al., 2021). Tirzepatide: up to 22.5% body weight loss over 72 weeks (SURMOUNT-1, Jastreboff et al., 2022). The medication is the primary determinant of outcomes. Provider-level differences in coaching and program structure produce modest incremental effects. Learn more about these medications on our semaglutide and tirzepatide treatment pages.
Pros and Cons: Hims vs Calibrate
Hims: Strengths
Month-to-month billing with no long-term contract or program fee
Fast onboarding — medication can arrive within days of completing the assessment
App-based platform provides convenient provider messaging and weight tracking
Transparent all-inclusive monthly pricing for medication and provider access
Freedom to cancel at any time without financial penalties
Offers both semaglutide and tirzepatide
Hims: Limitations
No one-on-one coaching or structured behavioral program
Provider interaction is primarily asynchronous messaging
Monthly pricing is $50 to $100+ more than the most affordable providers
No metabolic lab work or biomarker tracking built into the platform
Limited clinical depth compared to comprehensive programs
Calibrate: Strengths
Comprehensive twelve-month metabolic reset program addressing food, exercise, sleep, and emotional health
Dedicated one-on-one health coach with structured curriculum modules
Metabolic lab work provides thorough baseline data and progress tracking
Insurance navigation support for brand-name GLP-1 medication coverage
Designed for patients who thrive with intensive accountability and structure
Calibrate: Limitations
Requires $1,649 annual program fee on top of potential medication costs
One-year commitment locks you in even if the program is not the right fit
Medication costs may be separate from the program fee, creating total costs of $3,000-$6,000+ annually
Lab work and onboarding process can delay treatment initiation by weeks
Early cancellation may result in continued billing obligations
Comprehensive approach costs significantly more than medication-focused platforms
The Bottom Line: Choosing Between Hims, Calibrate, and Trimi
The right choice depends on what you value most in your GLP-1 weight loss journey: flexibility, comprehensiveness, or affordability.
Choose Hims if flexibility is your priority
Hims is a good fit for patients who want straightforward, month-to-month GLP-1 access without a long-term commitment. The app-based model is convenient, onboarding is fast, and there are no cancellation penalties. However, you will pay $50 to $200 more per month than the most affordable alternatives.
Choose Calibrate if you want maximum structure and can afford the premium
Calibrate makes sense for patients who genuinely want intensive coaching, structured behavioral programming, and metabolic lab tracking — and who have the budget and commitment tolerance for a year-long program. The coaching and curriculum are clinically sound, but only worth the cost if you will fully engage with every component.
Choose Trimi if you want the best value for effective GLP-1 therapy
Trimi offers the same medications at the lowest price point — $99/mo for semaglutide, $125/mo for tirzepatide — with board-certified provider oversight, no contracts, and no program fees. For patients who are self-motivated and primarily need affordable, clinically supervised medication access, Trimi saves $600 to $4,800+ per year compared to Hims and Calibrate.
Ultimately, GLP-1 medications are a long-term treatment. Most patients take them for twelve months or longer to achieve and sustain meaningful weight loss. The financial implications of provider choice compound over time: the difference between Calibrate and Trimi can exceed $4,800 per year, and even the difference between Hims and Trimi reaches $600 to $1,200 annually. Choosing a provider you can afford to stay with long enough for the medication to work is one of the most important decisions in your weight loss journey. Start your evaluation today with Trimi's free assessment.
Frequently Asked Questions
Is Hims or Calibrate cheaper for GLP-1 weight loss?
Hims is significantly cheaper on a monthly basis. Hims charges $149 to $199 per month for semaglutide and $199 to $299 per month for tirzepatide with no upfront commitment. Calibrate charges a $1,649 annual program fee plus separate medication costs, which can bring total annual spending to $3,000 or more. However, Trimi offers the lowest pricing at $99 per month for semaglutide and $125 per month for tirzepatide with no contracts or program fees.
Does Calibrate require a long-term contract?
Yes. Calibrate requires a one-year program commitment with a $1,649 annual fee that can be paid upfront or in monthly installments. Early termination may result in continued billing or cancellation penalties depending on the terms of your agreement. Hims and Trimi both operate on month-to-month billing with no long-term contracts required.
Does Hims offer coaching like Calibrate?
Hims does not offer one-on-one coaching comparable to Calibrate. Hims provides an app-based experience with provider messaging, weight tracking tools, and educational content. Calibrate includes a dedicated health coach, structured curriculum modules, and regular check-ins across food, exercise, sleep, and emotional health. The coaching difference is the primary reason Calibrate costs significantly more than Hims.
Can I switch from Calibrate to Hims or Trimi?
Yes, you can transition from Calibrate to either Hims or Trimi. Review your Calibrate contract for any early termination terms before canceling. When switching, share your current medication type, dose, and treatment history with your new provider so they can continue your therapy without interruption. Many patients switch from Calibrate to reduce costs while maintaining effective GLP-1 treatment.
Which provider has better medical oversight?
Both Hims and Calibrate employ licensed medical providers who oversee GLP-1 prescriptions. Calibrate emphasizes obesity medicine specialization and pairs medication with intensive behavioral coaching. Hims provides asynchronous provider consultations through its telehealth platform. Trimi offers board-certified providers with responsive clinical support. All three platforms provide legitimate medical oversight for GLP-1 therapy.
Do Hims and Calibrate offer tirzepatide?
Both Hims and Calibrate offer tirzepatide for weight loss. Hims prices tirzepatide at $199 to $299 per month. Calibrate may include tirzepatide through its program, though medication costs can vary based on insurance and formulation. Trimi offers tirzepatide at $125 per month, making it the most affordable option for dual GIP/GLP-1 receptor agonist therapy.
What happens if I want to stop treatment with Calibrate?
Stopping Calibrate treatment mid-program can be complicated due to the one-year commitment structure. Depending on your payment plan and contract terms, you may still owe the remaining balance of your annual program fee even after discontinuing treatment. This is one of the key reasons some patients prefer month-to-month providers like Hims or Trimi, where you can pause or cancel at any time without financial penalties.
Sources & References
- Wilding JPH, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity." New England Journal of Medicine, 2021;384(11):989-1002.
- Jastreboff AM, et al. "Tirzepatide Once Weekly for the Treatment of Obesity." New England Journal of Medicine, 2022;387(4):327-340.
- Wadden TA, et al. "Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity." JAMA, 2021;325(14):1403-1413.
- Hims & Hers Health, Inc. Official pricing and program information. 2026.
- Calibrate Health. Official pricing and program information. 2026.
- Wegovy (semaglutide) prescribing information. U.S. Food and Drug Administration.
- Zepbound (tirzepatide) prescribing information. U.S. Food and Drug Administration.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting any medication or treatment program. Pricing and program details are approximate, based on publicly available information as of April 2026, and subject to change. Verify current pricing directly with each provider. This article was prepared by the Trimi Medical Team and reviewed by Dr. Amanda Foster, MD. Trimi is a competing provider; this comparison is presented fairly but readers should independently verify all claims.